# FDA 483 - Central Solutions Inc - November 21, 2019

Source: https://www.keypedia.com/records/483/central-solutions-inc/07884c6b-ec69-4b46-9bac-9b64faac36a1

> FDA 483 for Central Solutions Inc on November 21, 2019. Product: drugs. Access full analysis and detailed observations.

---

## Details

- Record Type: 483
- Company Name: Central Solutions Inc
- Inspection Date: 2019-11-21
- Product Type: drugs
- Office Name: Division of Human and Animal Food Operations - West II
- Summary: An FDA inspection of Central Solutions Inc, an OTC drug, medical device, and cosmetic manufacturer in Kansas City, revealed significant deficiencies in quality control and manufacturing practices. The firm failed to thoroughly investigate discrepancies, justify deviations from specifications, and maintain adequate written procedures for production, process controls, and stability testing. Additionally, issues were noted with equipment cleaning, raw material release, and employee training.

## Related Documents

- [483 - 2025-04-02](https://www.keypedia.com/records/483/central-solutions-inc/9bd278c3-e407-4aca-8b7d-c2111fbb8abf)

## Related Officers

- [Rita Kabaso](https://www.keypedia.com/people/rita-kabaso/a8383d6d-b945-4edc-97a4-90944574835d)

Company: https://www.keypedia.com/companies/central-solutions-inc/e678531a-fef9-4225-8565-09b3e8fb1ae4

Office: https://www.keypedia.com/offices/division-of-human-and-animal-food-operations-west-ii/8851d151-0390-4d17-be66-fd86d12aa6b8